Evaluation of gastric electrophysiology, symptoms and quality of life after pancreaticoduodenectomy - Wang, Tim Hsu-Han; Varghese, Chris; Calder, Stefan; Gharibans, Armen; Schamberg, Gabriel; Bartlett, Adam; Srinivasa, Sanket; O’Grady, Greg (medRxiv, 2023)
Background Pancreaticoduodenectomy (PD) is an operation performed for several indications, including pancreatic and biliary malignancies. Delayed gastric emptying (DGE) is a common post-operative complication and the underlying pathophysiology remains poorly understood. This study aimed to evaluate the gastric electrophysiology, symptoms and quality of life following PD, using the novel non-invasive Gastric Alimetry System.Methods PD patients with index operations between 2017-2022 were assessed using the Gastric Alimetry System®, comprising a stretchable 8 exttimes8 electrode array, wearable Reader, and validated symptom logging app. A 30-minute pre-prandial and a 4-hour post-prandial recording was performed. Outcomes included Principal Gastric Frequency, BMI-adjusted amplitude, Gastric Alimetry Rhythm Index, meal response, symptoms, and quality of life (QOL) questionnaires (PAGI-SYM, PAGI-QOL). Data was compared to a validated reference range and matched healthy controls.Results 19 patients and 19 matched controls were recruited. There were no differences in any gastric parameters between PD patients and matched controls (all p>0.05). Gastric electrophysiology parameters lay outside normative reference intervals in 8/19 cases, generally being only minor deviations, while significant symptoms occurred in 8/19 (42%); which did not correlate (p=0.43). PD patients had worse quality of life scores than controls (p<0.01), however, no correlations were identified between electrophysiological parameters and QOL.Discussion Moderate to severe upper GI symptoms are common after PD with worse QOL compared to the controls. Gastric electrical activity generally recovers well long-term following PD, indicating that other factors contribute to symptoms. Further studies should now assess acute changes in gastric function after PD.Competing Interest StatementSC, AG and GOG are shareholders of Alimetry Ltd. There are no other conflicts of interest declared.Funding StatementThis work was supported by the New Zealand Health Research Council, The Royal Australasian College of Surgeons John Mitchell Crouch Fellowship (GOG), and the Auckland Medical Research Foundation Douglas Goodfellow Medical Research Fellowship (THHW).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Auckland Health Research Ethics Committee (ref AH1125)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors